Tekla Capital Management LLC Uni Qure N.V. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Tekla Capital Management LLC holds 356,280 shares of QURE stock, worth $6.2 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

356,280

Previous 652,446 45.39%

Holding current value

$6.2 Million

Previous $13.1 Million 68.93%

% of portfolio

0.16%

Previous 0.5%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$11.12 - $22.2 $3.29 Million - $6.57 Million	-296,166 Reduced 45.39%	356,280 $4.08 Million
Q4 2022 Feb 10, 2023	BUY	$18.12 - $27.32 $2.37 Million - $3.57 Million	130,753 Added 25.06%	652,446 $14.8 Million
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $5.76 Million - $10.3 Million	284,685 Added 120.12%	521,693 $10.8 Million
Q3 2021 Nov 12, 2021	BUY	$26.01 - $38.22 $288,372 - $423,745	11,087 Added 4.91%	237,008 $7.59 Million
Q2 2021 Aug 13, 2021	BUY	$29.97 - $37.17 $3.02 Million - $3.75 Million	100,918 Added 80.73%	225,921 $6.96 Million
Q4 2020 Feb 12, 2021	BUY	$35.35 - $50.67 $2.19 Million - $3.14 Million	61,964 Added 98.29%	125,003 $4.52 Million
Q2 2020 Aug 13, 2020	BUY	$45.06 - $67.74 $864,701 - $1.3 Million	19,190 Added 43.76%	63,039 $2.84 Million
Q1 2020 May 14, 2020	SELL	$40.01 - $73.97 $1.09 Million - $2.02 Million	-27,342 Reduced 38.41%	43,849 $2.08 Million
Q4 2019 Feb 13, 2020	BUY	$37.13 - $74.62 $1.02 Million - $2.04 Million	27,342 Added 62.35%	71,191 $5.1 Million
Q3 2019 Nov 13, 2019	BUY	$39.36 - $76.8 $948,497 - $1.85 Million	24,098 Added 122.01%	43,849 $1.73 Million
Q1 2019 May 14, 2019	SELL	$27.39 - $68.41 $492,746 - $1.23 Million	-17,990 Reduced 47.67%	19,751 $1.18 Million
Q2 2018 Aug 13, 2018	SELL	$21.96 - $39.94 $3.56 Million - $6.47 Million	-162,009 Reduced 81.11%	37,741 $1.43 Million
Q1 2018 May 14, 2018	SELL	$17.1 - $26.61 $2.28 Million - $3.54 Million	-133,100 Reduced 39.99%	199,750 $4.69 Million
Q4 2017 Feb 14, 2018	BUY	$9.47 - $19.59 $869,620 - $1.8 Million	91,829 Added 38.1%	332,850 $6.52 Million
Q2 2017 Aug 14, 2017	BUY	N/A	241,021	241,021 $1.49 Million

Others Institutions Holding QURE

# of Institutions

154

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $813M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Uni Qure N.V. Transaction History